+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Eubiotics Market Size, Share & Industry Trends Analysis Report By Product, By Application, By Form, By End-use, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 83 Pages
  • May 2022
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5615876
The North America Eubiotics Market is expected to witness market growth of 6.8% CAGR during the forecast period (2022-2028).

Eubiotics aids in the enhancement of the immune system and therefore plays an important role in it. Eubiotics are natural digestive stimulants that help to maintain a healthy bacteria balance in the gastrointestinal system. Dietary organic acids have a eubiotic influence on the multiplication of indigenous lactic acid bacteria, which helps to activate the immunological response to illnesses. Prebiotics, probiotics, and organic acids are examples of feed additives. Eubiotics are beneficial to digestive health and can be used in place of antibiotics in feed.

The term 'eubiosis' has entered the lexicon since routine use of antibiotics in cattle is no longer appropriate, and prophylactic/metaphylactic use is expected to be phased out in the coming years. It's a completely different approach to animal health, instead of attacking the microbiome with antibiotics, nurture and collaborate with the beneficial microorganisms. Eubiosis refers to the microflora of the gastrointestinal tract being in ideal balance. It is one of the most important variables in animal performance and immune development. Feed additives that have been demonstrated to promote eubiosis and overcome dysbiosis, or a mismatch in the microbiota of the gastrointestinal system, can be highly beneficial.

Probiotics described as "living microorganisms that impart a health benefit on the host when taken in suitable proportions," are finally becoming a viable alternative for gastroenterologists in Canada and the United States. Unfortunately, neither Health Canada nor the US Food and Drug Administration has implemented United Nations or World Health Organization standards to regulate the use of the term "probiotic." As a result, there is a slew of 'probiotic' products on the market that aren't probiotic. The purpose of this research was to explore the justification for probiotics in gastroenterology, along with the products available to physicians in Canada and which one’s patients may be taking.

For preweaning calves in USA dairy cattle, actual deaths of 5% and morbidity rates of 34% have been recorded. Furthermore, infections that occur during the newborn stage, particularly diarrhea, have a significant impact on growth throughout the raising phase, long-term future performance, and genetic potential for future herd improvements. It is crucial to provide feed additives to promote a neonatal calf's immunity and health, especially during the critical first weeks of life. Understanding the link between management techniques, dietary strategies, and calf health is critical for reducing morbidity and mortality while also increasing future production.

The US market dominated the North America Eubiotics Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $1,375 million by 2028. The Canada market is experiencing a CAGR of 9.3% during (2022 - 2028). Additionally, The Mexico market is expected to exhibit a CAGR of 8.3% during (2022 - 2028).

Based on Product, the market is segmented into Probiotics, Organic Acids, Phytogenic, Prebiotics, and Enzymes. Based on Application, the market is segmented into Gut Health, Immunity, Yield, and Others. Based on Form, the market is segmented into Solid and Liquid. Based on End-use, the market is segmented into Poultry Feed, Swine Feed, Cattle Feed, Aquatic Feed, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., Novozymes A/S, BASF SE, DuPont de Nemours, Inc., Chr. Hansen holding A/S, Lallemand, Inc., Lesaffre Group, Kemin Industries, Inc., Cargill Corporation, and Calpis Co., Ltd.

By Product

  • Probiotics
  • Organic Acids
  • Phytogenic
  • Prebiotics
  • Enzymes

By Application

  • Gut Health
  • Immunity
  • Yield
  • Others

By Form

  • Solid
  • Liquid

By End-use

  • Poultry Feed
  • Swine Feed
  • Cattle Feed
  • Aquatic Feed
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players


List of Companies Profiled in the Report:

  • Koninklijke DSM N.V.
  • Novozymes A/S
  • BASF SE
  • DuPont de Nemours, Inc.
  • Chr. Hansen holding A/S
  • Lallemand, Inc.
  • Lesaffre Group
  • Kemin Industries, Inc.
  • Cargill Corporation
  • Calpis Co., Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Eubiotics Market, by Product
1.4.2 North America Eubiotics Market, by Application
1.4.3 North America Eubiotics Market, by Form
1.4.4 North America Eubiotics Market, by End-use
1.4.5 North America Eubiotics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Eubiotics Market
Chapter 4. North America Eubiotics Market by Product
4.1 North America Probiotics Market by Country
4.2 North America Organic Acids Market by Country
4.3 North America Phytogenic Market by Country
4.4 North America Prebiotics Market by Country
4.5 North America Enzymes Market by Country
Chapter 5. North America Eubiotics Market by Application
5.1 North America Gut Health Market by Country
5.2 North America Immunity Market by Country
5.3 North America Yield Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Eubiotics Market by Form
6.1 North America Solid Market by Country
6.2 North America Liquid Market by Country
Chapter 7. North America Eubiotics Market by End-use
7.1 North America Poultry Feed Market by Country
7.2 North America Swine Feed Market by Country
7.3 North America Cattle Feed Market by Country
7.4 North America Aquatic Feed Market by Country
7.5 North America Others Market by Country
Chapter 8. North America Eubiotics Market by Country
8.1 US Eubiotics Market
8.1.1 US Eubiotics Market by Product
8.1.2 US Eubiotics Market by Application
8.1.3 US Eubiotics Market by Form
8.1.4 US Eubiotics Market by End-use
8.2 Canada Eubiotics Market
8.2.1 Canada Eubiotics Market by Product
8.2.2 Canada Eubiotics Market by Application
8.2.3 Canada Eubiotics Market by Form
8.2.4 Canada Eubiotics Market by End-use
8.3 Mexico Eubiotics Market
8.3.1 Mexico Eubiotics Market by Product
8.3.2 Mexico Eubiotics Market by Application
8.3.3 Mexico Eubiotics Market by Form
8.3.4 Mexico Eubiotics Market by End-use
8.4 Rest of North America Eubiotics Market
8.4.1 Rest of North America Eubiotics Market by Product
8.4.2 Rest of North America Eubiotics Market by Application
8.4.3 Rest of North America Eubiotics Market by Form
8.4.4 Rest of North America Eubiotics Market by End-use
Chapter 9. Company Profiles
9.1 Koninklijke DSM N.V.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisitions and Mergers:
9.1.5.3 Product Launches and Product Expansions:
9.2 Novozymes A/S
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 BASF SE
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.4 DuPont de Nemours, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Chr. Hansen Holding A/S
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Lallemand, Inc.
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Partnerships, Collaborations, and Agreements:
9.7 Lesaffre Group
9.7.1 Company Overview
9.7.2 Recent strategies and developments:
9.7.2.1 Partnerships, Collaborations, and Agreements:
9.8 Kemin Industries, Inc.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Product Launches and Product Expansions:
9.9 Cargill Corporation
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Product Launches and Product Expansions:
9.10. Calpis Co., Ltd. (Asahi Group Holdings, Ltd.)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental Analysis
9.10.4 Recent strategies and developments:
9.10.4.1 Approvals and Trials:

Companies Mentioned

  • Koninklijke DSM N.V.
  • Novozymes A/S
  • BASF SE
  • DuPont de Nemours, Inc.
  • Chr. Hansen holding A/S
  • Lallemand, Inc.
  • Lesaffre Group
  • Kemin Industries, Inc.
  • Cargill Corporation
  • Calpis Co., Ltd.

Methodology

Loading
LOADING...